These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 24052407

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. (E)-2,4-bis(p-hydroxyphenyl)-2-butenal has an antiproliferative effect on NSCLC cells induced by p38 MAPK-mediated suppression of NF-κB and up-regulation of TNFRSF10B (DR5).
    Kollipara PS, Jeong HS, Han SB, Hong JT.
    Br J Pharmacol; 2013 Mar; 168(6):1471-84. PubMed ID: 23082969
    [Abstract] [Full Text] [Related]

  • 3. (E)-2,4-Bis(p-hydroxyphenyl)-2-butenal enhanced TRAIL-induced apoptosis in ovarian cancer cells through downregulation of NF-κB/STAT3 pathway.
    Cho SH, Park MH, Lee HP, Back MK, Sung HC, Chang HW, Kim JH, Jeong HS, Han SB, Hong JT.
    Arch Pharm Res; 2014 May; 37(5):652-61. PubMed ID: 24390815
    [Abstract] [Full Text] [Related]

  • 4. (E)-4-(3-(3,5-dimethoxyphenyl)allyl)-2-methoxyphenol inhibits growth of colon tumors in mice.
    Zheng J, Park MH, Son DJ, Choi MG, Choi JS, Nam KT, Kim HD, Rodriguez K, Gann B, Ham YW, Han SB, Hong JT.
    Oncotarget; 2015 Dec 08; 6(39):41929-43. PubMed ID: 26474284
    [Abstract] [Full Text] [Related]

  • 5. Anti-arthritis effects of (E)-2,4-bis(p-hydroxyphenyl)-2-butenal are mediated by inhibition of the STAT3 pathway.
    Ban JO, Kim DH, Lee HP, Hwang CJ, Shim JH, Kim DJ, Kim TM, Jeong HS, Nah SS, Chen H, Dong Z, Ham YW, Kim Y, Han SB, Hong JT.
    Br J Pharmacol; 2014 Jun 08; 171(11):2900-12. PubMed ID: 24520814
    [Abstract] [Full Text] [Related]

  • 6. Growth Inhibitory Effect of (E)-2,4-bis(p-hydroxyphenyl)-2-Butenal Diacetate through Induction of Apoptotic Cell Death by Increasing DR3 Expression in Human Lung Cancer Cells.
    Lee US, Ban JO, Yeon ET, Lee HP, Udumula V, Ham YW, Hong JT.
    Biomol Ther (Seoul); 2012 Nov 08; 20(6):538-43. PubMed ID: 24009847
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB.
    Kasof GM, Lu JJ, Liu D, Speer B, Mongan KN, Gomes BC, Lorenzi MV.
    Oncogene; 2001 Nov 29; 20(55):7965-75. PubMed ID: 11753679
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. 2,4-bis (p-hydroxyphenyl)-2-butenal (HPB242) induces apoptosis via modulating E7 expression and inhibition of PI3K/Akt pathway in SiHa human cervical cancer cells.
    Kim MS, Kim JH, Bak Y, Park YS, Lee DH, Kang JW, Shim JH, Jeong HS, Hong JT, Yoon DY.
    Nutr Cancer; 2012 Nov 29; 64(8):1236-44. PubMed ID: 23163851
    [Abstract] [Full Text] [Related]

  • 12. Anti-cancer effect of bee venom on colon cancer cell growth by activation of death receptors and inhibition of nuclear factor kappa B.
    Zheng J, Lee HL, Ham YW, Song HS, Song MJ, Hong JT.
    Oncotarget; 2015 Dec 29; 6(42):44437-51. PubMed ID: 26561202
    [Abstract] [Full Text] [Related]

  • 13. Bee venom inhibits growth of human cervical tumors in mice.
    Lee HL, Park SH, Kim TM, Jung YY, Park MH, Oh SH, Yun HS, Jun HO, Yoo HS, Han SB, Lee US, Yoon JH, Song MJ, Hong JT.
    Oncotarget; 2015 Mar 30; 6(9):7280-92. PubMed ID: 25730901
    [Abstract] [Full Text] [Related]

  • 14. Tetraarsenic hexoxide demonstrates anticancer activity at least in part through suppression of NF-κB activity in SW620 human colon cancer cells.
    Lee WS, Yun JW, Nagappan A, Park HS, Lu JN, Kim HJ, Chang SH, Kim DC, Lee JH, Jung JM, Hong SC, Ha WS, Kim G.
    Oncol Rep; 2015 Jun 30; 33(6):2940-6. PubMed ID: 25845556
    [Abstract] [Full Text] [Related]

  • 15. A novel hydroxamic acid derivative, MHY218, induces apoptosis and cell cycle arrest through downregulation of NF-κB in HCT116 human colon cancer cells.
    Kim MK, Kang YJ, Kim DH, Hossain MA, Jang JY, Lee SH, Yoon JH, Chun P, Moon HR, Kim HS, Chung HY, Kim ND.
    Int J Oncol; 2014 Jan 30; 44(1):256-64. PubMed ID: 24190633
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Thiacremonone augments chemotherapeutic agent-induced growth inhibition in human colon cancer cells through inactivation of nuclear factor-{kappa}B.
    Ban JO, Lee HS, Jeong HS, Song S, Hwang BY, Moon DC, Yoon DY, Han SB, Hong JT.
    Mol Cancer Res; 2009 Jun 30; 7(6):870-9. PubMed ID: 19531569
    [Abstract] [Full Text] [Related]

  • 19. Inflexinol inhibits colon cancer cell growth through inhibition of nuclear factor-kappaB activity via direct interaction with p50.
    Ban JO, Oh JH, Hwang BY, Moon DC, Jeong HS, Lee S, Kim S, Lee H, Kim KB, Han SB, Hong JT.
    Mol Cancer Ther; 2009 Jun 30; 8(6):1613-24. PubMed ID: 19509257
    [Abstract] [Full Text] [Related]

  • 20. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
    Tse AK, Wan CK, Shen XL, Yang M, Fong WF.
    Biochem Pharmacol; 2005 Nov 15; 70(10):1443-57. PubMed ID: 16181613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.